Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × monalizumab × 30 days × Clear all

Phase

Status

Recruiting 2 Withdrawn 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Prednisone 3 Vincristine 2 Lenalidomide 2 Doxorubicin 2 Cyclophosphamide 2 tislelizumab 1 tazemetostat 1 tafasitamab 1 semaglutide 1 ribociclib 1 pembrolizumab 1 niraparib 1 monalizumab 1 fludarabine 1 etoposide phosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 auricularum 1 atezolizumab 1 Tiragolumab 1 Surveys and Questionnaires 1 Specimen Handling 1 Rituximab 1 Radiotherapy, Intensity-Modulated 1 Quality Assurance, Health Care 1 Prednisolone 1 Physical Therapy Modalities 1 Patient Education as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06152523 2026-04-06

MONAMI

Assistance Publique - Hôpitaux de Paris

Phase 2 Withdrawn

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡